
On March 1, EU Regulation to extend the European Medicines Agency’s (EMA) mandate came into effect, meaning that the agency’s more improvised role during the Covid-19 pandemic has now been set in stone.
The EMA ”is now responsible for monitoring medicine shortages that might lead to a crisis situation,” the agency writes in a news release.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app